Brain Type Natriuretic Peptide (BNP)-A Marker of New Millennium in Diagnosis of Congestive Heart Failure

Overview

Journal Indian J Clin Biochem

Specialty Biochemistry

Date 2012 Oct 30

PMID 23105644

Citations 7

Authors

Arun Raizada

Suman Bhandari

Muzaiyan Ahmed Khan

Harsh Vardhan Singh

Sherin Thomas

Vikram Sarabhai

Neelima Singh

Naresh Trehan

Affiliations

Soon will be listed here.

Abstract

The burden of disease in patients with congestive heart failure is high. The future of BNP looks promising as it may be a better diagnostic tool for the diagnosis of CHF in developing countries in new millennium. Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological properties, have emerged as important contenders for development of diagnostic tools and therapeutic agents in cardiovascular disease. Measurement of B-type natriuretic peptide has become as an easy-to-perform bedside test. The clinical and diagnostic significance of the measurement of plasma Nt-proBNP in the diseases of the cardiovascular system with particular emphasis on the assessment of patients with heart failure and their effects on predicting survival rate. The plasma levels of Nt-proBrain Natriuretic peptide responds more vigorously after myocardial infarction than those of other natriuretic peptides. This article is an attempt to give a short overview on the utility of BNP-blood levels for the diagnosis and treatment of heart failure.

Citing Articles

Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis.

Kuai Z, Ma Y, Gao W, Zhang X, Wang X, Ye Y Heliyon. 2024; 10(19):e37929.

PMID: 39386873 PMC: 11462209. DOI: 10.1016/j.heliyon.2024.e37929.

Proteomic Studies of Blood and Vascular Wall in Atherosclerosis.

Stakhneva E, Striukova E, Ragino Y Int J Mol Sci. 2021; 22(24).

PMID: 34948066 PMC: 8707794. DOI: 10.3390/ijms222413267.

Diagnosing cardiovascular disease in western lowland gorillas (Gorilla gorilla gorilla) with brain natriuretic peptide.

Murray S, Kishbaugh J, Hayek L, Kutinsky I, Dennis P, Devlin W PLoS One. 2019; 14(3):e0214101.

PMID: 30889217 PMC: 6424555. DOI: 10.1371/journal.pone.0214101.

Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.

Hogas S, Bilha S, Branisteanu D, Hogas M, Gaipov A, Kanbay M Arch Med Sci. 2017; 13(4):897-913.

PMID: 28721158 PMC: 5507105. DOI: 10.5114/aoms.2016.58664.

Novel Risk Stratification Assays for Acute Coronary Syndrome.

Ahmed H, Hazen S Curr Cardiol Rep. 2017; 19(8):69.

PMID: 28653131 PMC: 5998330. DOI: 10.1007/s11886-017-0880-8.

References

Thuerauf D, Glembotski C . Differential effects of protein kinase C, Ras, and Raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal M-CAT element. J Biol Chem. 1997; 272(11):7464-72. DOI: 10.1074/jbc.272.11.7464. View

Kucher N, Printzen G, Doernhoefer T, Windecker S, Meier B, Hess O . Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation. 2003; 107(12):1576-8. DOI: 10.1161/01.CIR.0000064898.51892.09. View

Hervas I, Arnau M, Almenar L, Perez-Pastor J, Chirivella M, Osca J . Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures. Lab Invest. 2003; 84(1):138-45. DOI: 10.1038/labinvest.3700011. View

Buckley M, Sethi D, Markandu N, Sagnella G, Singer D, Macgregor G . Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond). 1992; 83(4):437-44. DOI: 10.1042/cs0830437. View

Omland T, AAKVAAG A, Bonarjee V, Caidahl K, Lie R, Nilsen D . Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996; 93(11):1963-9. DOI: 10.1161/01.cir.93.11.1963. View

James S, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P . N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded.... Circulation. 2003; 108(3):275-81. DOI: 10.1161/01.CIR.0000079170.10579.DC. View

Ikeda T, Matsuda K, Itoh H, Shirakami G, Miyamoto Y, Yoshimasa T . Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J. 1997; 133(3):307-14. DOI: 10.1016/s0002-8703(97)70225-4. View

Nakamura M, Endo H, Nasu M, Arakawa N, Segawa T, Hiramori K . Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart. 2002; 87(2):131-5. PMC: 1767000. DOI: 10.1136/heart.87.2.131. View

Yoshimura M, Mizuno Y, Nakayama M, Sakamoto T, Sugiyama S, Kawano H . B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure. Am J Med. 2002; 112(9):716-20. DOI: 10.1016/s0002-9343(02)01121-x. View

10.

Yandle T, Richards A, Gilbert A, Fisher S, Holmes S, Espiner E . Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 1993; 76(4):832-8. DOI: 10.1210/jcem.76.4.8473392. View

11.

Holtwick R, van Eickels M, Skryabin B, Baba H, Bubikat A, Begrow F . Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest. 2003; 111(9):1399-407. PMC: 154444. DOI: 10.1172/JCI17061. View

12.

Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T . Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993; 88(1):82-91. DOI: 10.1161/01.cir.88.1.82. View

13.

Weber M, Hamm C . Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006; 92(6):843-9. PMC: 1860679. DOI: 10.1136/hrt.2005.071233. View

14.

Yamamoto K, Burnett Jr J, Jougasaki M, Nishimura R, Bailey K, Saito Y . Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996; 28(6):988-94. DOI: 10.1161/01.hyp.28.6.988. View

15.

Hautala N, Tokola H, Luodonpaa M, Puhakka J, Romppanen H, Vuolteenaho O . Pressure overload increases GATA4 binding activity via endothelin-1. Circulation. 2001; 103(5):730-5. DOI: 10.1161/01.cir.103.5.730. View

16.

Kambayashi Y, Nakao K, Mukoyama M, Saito Y, Ogawa Y, Shiono S . Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 1990; 259(2):341-5. DOI: 10.1016/0014-5793(90)80043-i. View

17.

Henriksen J, Gotze J, Fuglsang S, Christensen E, Bendtsen F, Moller S . Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut. 2003; 52(10):1511-7. PMC: 1773816. DOI: 10.1136/gut.52.10.1511. View

18.

Fisher C, Berry C, Blue L, Morton J, McMURRAY J . N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart. 2003; 89(8):879-81. PMC: 1767758. DOI: 10.1136/heart.89.8.879. View

19.

Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B . B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002; 105(20):2392-7. DOI: 10.1161/01.cir.0000016642.15031.34. View

20.

Matsumoto A, Hirata Y, Momomura S, Suzuki E, Yokoyama I, Sata M . Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 1995; 129(1):139-45. DOI: 10.1016/0002-8703(95)90054-3. View